The prognosis of HZO is highly variable and largely dependent on the patientâ€™s risk factors, the timing of treatment, and the aggressiveness of the disease. There is limited data on the morbidity and mortality rates of HZO. However, most immunocompetent patients with herpes zoster who receive early treatment have a resolution of lesions within four weeks and can be managed outpatient.